The World Health Organization (WHO) has confirmed that Nigeria will soon receive essential medication to treat leprosy, marking an end to a year-long shortage affecting thousands of patients. Over 2,000 new cases of leprosy are reported annually in Nigeria, but due to the introduction of new regulations partly responsible for the drug shortages, many patients have been left without treatment.
The WHO has urged Nigeria to temporarily lift its stringent new testing policy, allowing vital drugs to be imported from India, with an expected arrival date of Sunday. Leprosy is treatable with a combination of antibiotics, yet untreated patients may suffer severe health complications including sores, nerve damage, and deformities. The treatment course lasts between six and twelve months and is crucial in disrupting disease transmission.
Dr. Samimu Msheliza, a public health expert with the Nigerian branch of the Leprosy Mission, emphasized the pressing need for these medications, stating, "Thousands of newly diagnosed leprosy patients across various cities are just waiting for this drug." He expressed concerns that without timely access to treatment, not only do patients suffer, but the potential for further spread of the disease increases as others remain untreated.
One patient, Awwal Musa from Nasarawa state, shared her distress over the lack of available treatments, describing the worsening of her condition. "Before last year, my wounds were getting healed, but now they are getting worse," Musa reported, highlighting the urgent need for the antibiotics.
Despite aims to combat counterfeit and sub-standard medications through new regulations, the measures have inadvertently led to a critical shortage of life-saving drugs for leprosy. As Nigeria awaits the arrival of these drugs, the focus remains on restoring treatment access and ensuring patient health is prioritized to avert further complications.
The WHO has urged Nigeria to temporarily lift its stringent new testing policy, allowing vital drugs to be imported from India, with an expected arrival date of Sunday. Leprosy is treatable with a combination of antibiotics, yet untreated patients may suffer severe health complications including sores, nerve damage, and deformities. The treatment course lasts between six and twelve months and is crucial in disrupting disease transmission.
Dr. Samimu Msheliza, a public health expert with the Nigerian branch of the Leprosy Mission, emphasized the pressing need for these medications, stating, "Thousands of newly diagnosed leprosy patients across various cities are just waiting for this drug." He expressed concerns that without timely access to treatment, not only do patients suffer, but the potential for further spread of the disease increases as others remain untreated.
One patient, Awwal Musa from Nasarawa state, shared her distress over the lack of available treatments, describing the worsening of her condition. "Before last year, my wounds were getting healed, but now they are getting worse," Musa reported, highlighting the urgent need for the antibiotics.
Despite aims to combat counterfeit and sub-standard medications through new regulations, the measures have inadvertently led to a critical shortage of life-saving drugs for leprosy. As Nigeria awaits the arrival of these drugs, the focus remains on restoring treatment access and ensuring patient health is prioritized to avert further complications.
